Zenotech Laboratories Limited

BOM:532039 ISIN:INE486F01012

2012年5月25日

概覽 | 新聞 | 多媒體 | 研究

Zenotech Laboratories Limited 公司資料

Zenotech Laboratories Limited (Zenotech) is an India-based company that is principally engaged in the manufacture and trading of pharmaceuticals. The Company has launched 15 generic chemical oncology and anesthesiology products in India. Zenotech has three biological products: recombinant human granulocyte macrophage-colony stimulating factor (GM-CSF), recombinant human granulocyte colony stimulating factor (G-CSF) and interlukin-2 (IL-2). All the three are used in the cancer therapy area. The Company’s wholly owned subsidiaries include Zenotech Farmaceutica Do Brasil Limitada, Zenotech Laboratories Nigeria Limited and Zenotech Inc. On May 31, 2007, the Company incorporated a wholly owned subsidiary Hemarus Biologicals Limited.

公司詳細

	主要部門	醫療-製藥

	支柱產業	生物科技

	主頁	www.zenotechlabs.com

Key Developments: Zenotech Laboratories Limited

	1月22日澳洲股市：賣空禁令助市 JAN 22, 2009 13:00 - Article Views: 9,911 因為市場對全球銀行業的擔憂被再度引發，昨天澳洲股市在金融股的拖累下收低。基本指數S&P/ASX200下跌1%，或33.8點，報3442.8點，綜合指數下跌0.9%，或30.2點，報3394.8點。監管機構澳大利亞證券投資委員會決定延長禁止進行有擔保的金融債券賣空交易的期限，或將給銀行業帶來積極推動。